Anaphylaxis to sunflower seed / Anafilaxia à semente de girassol

Sunflower seed (Helianthus annuus) is an uncommon allergenic source frequently consumed in snacks, as component of some types of bread, as condiment in some dishes, and also used in animal feeding. Occasional cases of anaphylaxis to this seed have been reported in the current literature, mainly in workers occupationally exposed to sunflower allergens and bird breeders. The allergenic nature of the storage protein albumin 2S and the non-specific lipid transfer protein (nsLTP) of this seed has been described. The authors report the case and diagnostic approach of a seed anaphylaxis.

A semente de girassol (Helianthus annuus) é uma fonte alergênica incomum frequentemente consumida em lanches, como componente de alguns tipos de pães, como condimento em alguns pratos, e também utilizada na alimentação animal. Casos eventuais de anafilaxia a esta semente têm sido relatados na literatura atual, principalmente em trabalhadores com exposição ocupacional a alérgenos de girassol e criadores de aves. A natureza alergênica da proteína de armazenamento albumina 2S e da proteína não específica de transferência de lipídios (nsLTP) dessa semente foi descrita. Os autores relatam o caso e a abordagem diagnóstica de uma anafilaxia por sementes.

Occupational rhinoconjunctivitis to cyclamen: A case report / Rinoconjuntivite ocupacional a cyclamen - Caso clínico

Cyclamen is a plant belonging to the Primulaceae family, widely used as an indoor ornamental flowering plant. Occupational allergy to cyclamen has been occasionally described in the current literature. The authors intend to report the case and diagnostic approach of a suspected occupational cyclamen allergy.

O ciclame é uma planta pertencente à família Primulaceae, amplamente utilizada como planta ornamental de interior. A alergia ocupacional ao ciclame raramente foi descrita na literatura. Os autores pretendem descrever um caso e abordagem diagnóstica de uma suspeita de alergia ocupacional ao ciclame.

Breast cancer screening adherence rates and barriers of implementation in ethnic, cultural and religious minorities: A systematic review.

Breast cancer is the most common cancer affecting women worldwide. Adherence to breast cancer screening guidelines is frequently lower in racial, ethnic and cultural minority populations and is affected by potential inequities or barriers to screening that these minorities face. Therefore, the aim of the present study was to collect information from different minority groups worldwide, assess adherence to breast cancer screening and evaluate barriers or limitations causing non-adherence, which should facilitate the development of effective interventions. A search was conducted through PubMed and Web of Science. Studies were considered as eligible if they met the following criteria: i) Female patients; ii) breast cancer screening program implemented in the country; iii) minority groups; iv) asymptomatic; v) report written in Portuguese or English; vi) study published from 2015 onwards. The Critical Appraisal Skills Programme checklist was used for qualitative studies and the Strengthening The Reporting of Observational Studies in Epidemiology checklist for cross-sectional studies. From the 348 initial articles, 86 were removed due to duplication and 19 were selected, analyzed and summarized, accordingly. Of the 19 studies included, 5.3% were classified as high quality, 52.6% as moderate to high and 42.1% as moderate. A total of 15 studies were cross-sectional and 4 were qualitative, collectively including 250,733 women. The rate of adherence to mammogram in different minorities was evaluated, obtaining a mean value of 49.7% in the last 2 years, and statistically significant barriers were selected and divided into sociodemographic; personal; ethnic, cultural and religious; and external factors. The characteristics of each population play a major role in the population's breast health practices. If the population, adherence rates, barriers and inequities are carefully studied, screening models may be customized and participation to breast cancer screening can be optimized, thereby reducing the high breast cancer-associated mortality.